Dietary Supplements And FDA: Potential For Partnership?

Law360 (March 7, 2018, 1:15 PM EST) -- On Aug. 18, 2017, dietary supplement ingredient supplier ChromaDex filed a citizen petition requesting that the U.S. Food and Drug Administration "investigate and take appropriate remedial action" against Elysium Health Inc., which markets the dietary supplement Basis. The petition, filed against a backdrop of bicoastal litigation between Elysium and ChromaDex, alleges that samples of Elysium's Basis dietary supplement contained an industrial solvent, toluene, at 94-144 milligrams per kilogram (mg/kg), and also contained lead and molybdenum.[1] The citizen petition and its assertions were surprising and unexpected, especially given Elysium's history and prominence in the dietary supplement industry.

Elysium is, by all accounts,...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!